Skip to content
DataLookout
Menu

Changes this week

Changes detected in the 7 days to Nov 21, 2026

  1. Minor: Sensory Neurography and S2PD, a Test-Retest Study Study completion pushed from May 2026 to Dec 31, 2026 Karolinska InstitutetNot applicable NCT07605585
  2. Minor: Diode Laser, Gudmar and Vinegar in Diabetic Patients During Root Canal Treatment Study completion moved earlier from May 1, 2027 to Dec 31, 2026 Sharda UniversityNot applicable NCT07549373
  3. Minor: IParent2Parent Program for Parents of Pediatric Solid Organ Transplant Recipients Study completion pushed from Jun 26, 2026 to Mar 31, 2027 The Hospital for Sick ChildrenNot applicable NCT05968807
  4. Minor: Intra-arterial Thrombolysis for Acute Ischemic Stroke With Medium Vessel Occlusion Interventions modified The Second Hospital of Anhui Medical UniversityNot applicable NCT07185022
  5. Minor: COINCIDE · Cardineurovascular dIsease and Obstructive Airway Disease Start date pushed from Oct 15, 2026 to Nov 2026 VASCage GmbHNot specified NCT07856667
  6. Minor: Using Facebook to Support Opioid Recovery Among American Indian Women Study completion pushed from Oct 31, 2026 to Oct 15, 2027 Mayo ClinicNot applicable NCT05995886
  7. Minor: Music Improvisation Training on Cognitive Function in Older Adults Study completion pushed from Jun 12, 2026 to Jun 12, 2027 University of California, San FranciscoNot applicable NCT06721390
  8. Minor: CHIP in Health and Disease Start date pushed from Oct 2026 to Nov 2026 VASCage GmbHNot specified NCT07780552
  9. Minor: Maastro Applicator in Rectal Cancer Study completion moved earlier from Apr 2031 to Oct 6, 2030 Maastricht Radiation OncologyNot applicable NCT06087718
  10. Minor: MDMA-assisted Therapy for Fibromyalgia Trial arms changed: 0 → 1 Spaulding Rehabilitation HospitalEarly Phase 1 NCT06066853
  11. Stopped: SSGJ-707 in Advanced Non-Small Cell Lung Cancer Trial terminated Shenyang Sunshine Pharmaceutical Co., LTD.Phase 3 NCT06980272
  12. Stopped: Oral Weekly Lepetegravir (Formerly GS-1720) and Lenacapavir Pacfosacil (Formerly GS-4182) Versus Biktarvy · HIV-1 Who Are Virologically Suppressed Trial terminated Gilead SciencesPhase 2/3 NCT06544733
  13. Stopped: Azetukalner Versus Placebo in Major Depressive Disorder Trial terminated Xenon Pharmaceuticals Inc.Phase 3 NCT06775379
  14. Stopped: Electrical Vestibular Nerve Stimulation (VeNS) as a Treatment for Major Depressive Disorder (MDD) Withdrawn before enrolling Neurovalens Ltd.Not applicable NCT06470035
  15. Stopped: AK104 (Cadonilimab) for Recurrent Small Cell Neuroendocrine Carcinomas of the Cervix Trial terminated M.D. Anderson Cancer CenterPhase 2 NCT05063916
  16. Stopped: Two Step Haplo With Radiation Conditioning Recruitment suspended Thomas Jefferson UniversityPhase 2 NCT05031897
  17. Stopped: Mozobil for Autologous Hematopoietic Stem Cell Transplantation Recruitment suspended Thomas Jefferson UniversityPhase 2 NCT07188090
  18. Stopped: Anti-Inflammatory Treatment of Uremic Cardiomyopathy With Colchicine Trial terminated Brigham and Women's HospitalPhase 2 NCT04500665
  19. Stopped: Spine Radiosurgery for Symptomatic Metastatic Neoplasms Recruitment suspended University of OklahomaPhase 2 NCT05617716
  20. Stopped: Breast-milk Enema Administration to Stimulate Passage of Meconium Withdrawn before enrolling Wake Forest University Health SciencesPhase 1 NCT07661992
  21. Stopped: Respiratory Muscle Strength Training to Prevent Respiratory Muscle Weakness in Adults Newly Diagnosed With Breast Cancer Withdrawn before enrolling University of FloridaNot applicable NCT07229378
  22. Stopped: Level Up! Adaptive Gaming · Upper Limb Differences Trial status changed: Recruiting → Withdrawn University of ManitobaNot applicable NCT05981664
  23. Stopped: CHAMP Lung Cancer Screening Program Recruitment suspended Jill KolesarNot applicable NCT07572773
  24. Stopped: OCRA Distress & Unmet Needs Trial status changed: Not Yet Recruiting → Suspended M.D. Anderson Cancer CenterNot applicable NCT07591623
  25. Notable: Fixed Order, Open-Label, Dose-Escalation Study of DMT in Humans Enrollment reduced: 30 → 10 participants Yale UniversityPhase 1 NCT04711915